[1]
S. M. Jungić, B. Tubić, R. Gajanin, Z. Gojković, and I. Rakita, “Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal cancer”, Vojnosanit Pregl, vol. 74, no. 3, pp. 249–255, Jun. 2017, doi: 10.2298/VSP150513173J.